Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry

Assessment of the high risk and unmet need in patients with CAD and type 2 diabetes (ATHENA): US healthcare resource utilization, cost and burden of illness in the Diabetes Collaborative Registry

Abstract Background THEMIS (NCT01991795) showed that in patients with type 2 diabetes (T2D) and stable coronary artery disease (CAD) but with no prior myocardial infarction (MI) or stroke, ticagrelor plus acetylsalicylic acid (ASA) decreased the incidence of ischaemic cardiovascular events compared...

Full description

Bibliographic Details
Main Authors: Eric Wittbrodt, Narinder Bhalla, Karolina Andersson Sundell, Qi Gao, Liyan Dong, Matthew A. Cavender, Phillip Hunt, Nathan D. Wong, Carl Mellström
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
antiplatelet agent
cardiovascular disease prevention
cardiovascular events
epidemiology
type 2 diabetes mellitus
Online Access:https://doi.org/10.1002/edm2.133

Internet

https://doi.org/10.1002/edm2.133

Similar Items